Uveal Melanoma Metastatic to the Liver: The Role of Quantitative Volumetric Contrast-Enhanced MR Imaging in the Assessment of Early Tumor Response after Transarterial Chemoembolization
Duran R, Chapiro J, Frangakis C, Lin M, Schlachter TR, Schernthaner RE, Wang Z, Savic LJ, Tacher V, Kamel IR, Geschwind JF. Uveal Melanoma Metastatic to the Liver: The Role of Quantitative Volumetric Contrast-Enhanced MR Imaging in the Assessment of Early Tumor Response after Transarterial Chemoembolization. Translational Oncology 2014, 7: 447-455. PMID: 24953419, PMCID: PMC4202794, DOI: 10.1016/j.tranon.2014.05.004.Peer-Reviewed Original ResearchFirst transarterial chemoembolizationEarly tumor responseTransarterial chemoembolizationWorld Health OrganizationOverall survivalTumor responseTarget lesionsTumor volumeTumor enhancementUveal melanomaContrast-enhanced magnetic resonance imagingNon-target lesionsUveal melanoma metastaticMedian overall survivalResponse Evaluation CriteriaKaplan-Meier methodLog-rank testMetastatic uveal melanomaMagnetic resonance imagingMelanoma metastaticSurrogate biomarkerSolid tumorsResonance imagingResponse criteriaLesions2:42 PM Abstract No. 45 Uveal melanoma metastatic to the liver: the role of quantitative and functional MR imaging in the assessment of early tumor response after TACE
Duran R, Chapiro J, Lin M, Frangakis C, Lesage D, Schlachter T, Tacher V, Wang Z, Geschwind J. 2:42 PM Abstract No. 45 Uveal melanoma metastatic to the liver: the role of quantitative and functional MR imaging in the assessment of early tumor response after TACE. Journal Of Vascular And Interventional Radiology 2014, 25: s27. DOI: 10.1016/j.jvir.2013.12.063.Peer-Reviewed Original ResearchUveal melanoma metastaticEarly tumor responseMelanoma metastaticTumor responseFunctional MRMetastaticTACELiver